COX-2: Where are we in 2003? - Be strong and resolute: continue to use COX-2 selective inhibitors at recommended dosages in appropriate patients

Cyclooxygenase (COX)-2 selective inhibitors have been shown to have comparable efficacy to nonselective nonsteroidal anti-inflammatory drugs (NSAIDs) in the treatment of patients with osteoarthritis (OA) and rheumatoid arthritis (RA). Large outcome studies have shown that patients with OA and RA not...

Descripción completa

Detalles Bibliográficos
Autor principal: Hochberg, Marc C
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC154435/
https://www.ncbi.nlm.nih.gov/pubmed/12716445
http://dx.doi.org/10.1186/ar617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC154435/
https://www.ncbi.nlm.nih.gov/pubmed/12716445
http://dx.doi.org/10.1186/ar617

Ejemplares similares